Federal Register / Vol. 76, No. 3 / Wednesday, January 5, 2011 / Notices 575 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Cancer 

Institute Clinical Trials and Translational 

Research Advisory Committee. 

Date: March 3, 2011. 

Time: 9 a.m. to 4 p.m. 

Agenda: Strategic Discussion of NCI’s 

Clinical and Translational Research 

Programs. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C-wing, 6th 

Floor, Conference Rooms, Bethesda, MD 

20892. 

Contact Person: Sheila A. Prindiville, MD, 

MPH, Director, Coordinating Center for 

Clinical Trials, Office of the Director, 

National Cancer Institute, National Institutes 

of Health, 6120 Executive Blvd., 3rd Floor 

Suite, Bethesda, MD 20892, 301–451–5048, 

prindivs@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 28, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–33321 Filed 1–4–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Initial Review Group; Neuroscience of 

Aging Review Committee. 

Date: March 3–4, 2011. 

Time: 4 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: William Cruce, PhD, 

Scientific Review Administrator, National 

Institute on Aging, Scientific Review Office, 

Gateway Building 2C–212, 7201 Wisconsin 

Ave., Bethesda, MD 20814, 301–402–7704, 

crucew@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 28, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–33320 Filed 1–4–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; ADCC 

Meeting. 

Date: February 24–25, 2011. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott Chevy Chase, 

5520 Wisconsin Avenue, Chevy Chase, MD 

20815. 

Contact Person: Elaine Lewis, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, Gateway 

Building, Suite 2C212, MSC–9205, 7201 

Wisconsin Avenue, Bethesda, MD 20892, 

301–402–7707, elainelewis@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 28, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–33319 Filed 1–4–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel Projects in MRSA. 

Date: January 12, 2011. 

Time: 3:30 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817 

(Telephone Conference Call). 

Contact Person: Yong Gao, PhD, Scientific 

Review Officer, Scientific Review Program, 

DHHS/NIH/NIAID, 6700B Rockledge Drive, 

Room 3246, Bethesda, MD 20892, 301–443– 

8115, gaol2@niaid.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 


jlentini on DSKJ8SOYB1PROD with NOTICES
576 Federal Register / Vol. 76, No. 3 / Wednesday, January 5, 2011 / Notices 

Dated: December 28, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–33239 Filed 1–4–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

President’s Cancer Panel. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: President’s Cancer 

Panel. 

Date: February 1, 2011. 

Time: 8 a.m. to 4 p.m. 

Agenda: The Future of Cancer Research: 

Accelerating Scientific Innovation. 

Place: Grand Hyatt Atlanta, 3300 Peachtree 

Road, NE., Atlanta, GA 30305. 

Contact Person: Abby B. Sandler, PhD, 

Executive Secretary, Chief, Institute Review 

Office, Office of the Director, 6116 Executive 

Blvd., Suite 220, MSC 8349, National Cancer 

Institute, NIH, Bethesda, MD 20892–8349, 

(301) 451–9399, sandlera@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/pcp/pcp.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 28, 2010. 

Anna P. Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–33291 Filed 1–4–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SPORE in 

Mesothelioma, Lung, Breast and Ovarian 

Cancers. 

Date: February 2–3, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Wlodek Lopaczynski, 

M.D., PhD, Scientific Review Officer, 

Research Programs Review Branch, Division 

of Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8131, 

Bethesda, MD 20892, 301–594–1402, 

lopacw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Development of Molecular Diagnostics Assay 

to Detect Basal-like Breast Cancer. 

Date: February 15, 2011. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 703, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Lalita D. Palekar, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 7141, Bethesda, 

MD 20892, 301–496–7575, 

palekarl@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Systems for 

Automated Storage, Analysis, and Reporting 

of Objective Behavioral Exposures. 

Date: February 16–17, 2011. 

Time: 8:30 a.m. to 11 a.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Legacy Hotel and Meeting Center, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: Ellen K Schwartz, E.D.D., 

M.B.A., Scientific Review Officer, Special 

Review & Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8055B, Bethesda, MD 20892–8329, 

301–594–1215, schwarel@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Collaborative Research in Integrative Cancer 

Biology and the Tumor Microenvironment. 

Date: February 16, 2011. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 8055A, 

Rockville, MD 20852, (Telephone Conference 

Call) 

Contact Person: Zhiqiang Zou, M.D., PhD, 

Scientific Review Officer, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8055A, MSC 8329, 

Bethesda, MD 20852, zouzhiq@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Smartphone Applications for Cancer 

Prevention and Control. 

Date: February 17, 2011. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Legacy Hotel and Meeting Center, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: Ellen K Schwartz, E.D.D., 

M.B.A., Scientific Review Officer, Special 

Review & Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8055B, Bethesda, MD 20892–8329, 

301–594–1215, schwarel@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Nanotechnology Sensing Platforms. 

Date: March 2, 2011. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Savvas C Makrides, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Blvd., Rm 8050a, Bethesda, 

MD 20892, 301–496–7421, 

makridessc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Innovative 

Technology Development. 

Date: March 2–3, 2011. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Legacy Hotel and Meeting Center, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: Jeffrey E. DeClue, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8059, 

Bethesda, MD 20892–8329, 301–496–7904, 

decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 


jlentini on DSKJ8SOYB1PROD with NOTICES